Sort

Search

02/01/2022 Validity of the Sedentary Behavior Questionnaire in European Older Adults Using English, Spanish, German and Danish Versions
Sansano-Nadal, O, Wilson, JJ, Martin-Borras, C, Brond, JC, Skjodt, M, Caserotti, P, Figuls, MRI, Blackburn, NE, Klenk, J, Rothenbacher, D, Guerra-Balic, M, Font-Farre, M, Denkinger, M, Coll-Planas, L, Deidda, M, McIntosh, E, Gine-Garriga, M, Tully, MA. Validity of the Sedentary Behavior Questionnaire in European Older Adults Using English, Spanish, German and Danish Versions. Measurement in Physical Education and Exercise Science. 2022; 26(1)DOI:10.1080/1091367X.2021.1922910. PMID:. IF:2.100(Q3/7D).
02/01/2022 Establishment and validation of surface model for biodosimetry based on gamma-H2AX foci detection
Lopez, JS, Pujol-Canadell, M, Puig, P, Ribas, M, Carrasco, P, Armengol, G, Barquinero, JF. Establishment and validation of surface model for biodosimetry based on gamma-H2AX foci detection. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. 2022; 98(1)DOI:10.1080/09553002.2022.1998706. PMID:34705602. IF:2.600(Q1/3D).
02/01/2022 Bilateral Marginal Corneal Infiltrates: A Novel Ocular Manifestation of DRESS Syndrome
Vela, JI, Bulnes, V, Torrell, N, Giro, M, Perich, S. Bilateral Marginal Corneal Infiltrates: A Novel Ocular Manifestation of DRESS Syndrome. OCULAR IMMUNOLOGY AND INFLAMMATION. 2022; 30(1)DOI:10.1080/09273948.2020.1797111. PMID:32816571. IF:3.300(Q2/3D).
02/01/2022 A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Lopez-Guillermo, A, Canales, MA, Dlouhy, I, Mercadal, S, Briones, J, Garcia-Sancho, AM, Sancho, JM, Moraleda, JM, Terol, MJ, Salar, A, Palomera, L, Gardella, S, Jarque, I, Ferrer, S, Bargay, J, Lopez, A, Panizo, C, Muntanola, A, Montalban, C, Conde, E, Hernandez, MT, Soler, A, Marco, JAG, Deben, G, Marin, J, Tomas, JF. A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. LEUKEMIA & LYMPHOMA. 2022; 63(1)DOI:10.1080/10428194.2021.1971216. PMID:34459702. IF:2.600(Q3/7D).